갑상선 양성 결절에서 갑상선 호르몬 억제요법의 효과
Effectiveness of Suppressive Therapy with Levothyroxine in Benign Thyroid Nodules
0
조회
0
다운로드
1
인용
0
참고문헌
초록
Background and Objectives The effectiveness of suppressive therapy with Levothyroxine in benign thyroid nodule is controversial. The favorable response varies between 9-68%. The aim of this study was to evaluate the effect of Levothyroxine suppressive therapy on benign thyroid nodules in comparison with untreated patients. Subjects and Method A total 98 patients diagnosed with benign thyroid nodules by high resolution ultrasonography and fine needle aspiration cytology from January 2001 to June 2007 was evaluated retrospectively. The case group included 55 patients who received Levothyroxine suppressive therapy for longer than 6 months with documentation of thyroid stimulating hormone (TSH) suppression level. The control group included 43 patients who were followed up without any treatment. We measured TSH, free T4, and thyroid nodule volume by ultrasound every 6 months. Results In 13 patients (23.6%) of the case group, nodule volume decreased more than 50% after the Levothyroxine suppressive therapy. In 10 (23.2%) of the control group, nodule volume decreased more than 50 % after the follow-up of 6 months. There was no significant difference between the two groups. The change of nodule volume was not related to the TSH suppression level, the number of nodule or the type of nodule. Conclusion We concluded that Levothyroxine suppressive therapy was not effective in volume reduction of benign thyroid nodules.
Abstract
Background and Objectives The effectiveness of suppressive therapy with Levothyroxine in benign thyroid nodule is controversial. The favorable response varies between 9-68%. The aim of this study was to evaluate the effect of Levothyroxine suppressive therapy on benign thyroid nodules in comparison with untreated patients. Subjects and Method A total 98 patients diagnosed with benign thyroid nodules by high resolution ultrasonography and fine needle aspiration cytology from January 2001 to June 2007 was evaluated retrospectively. The case group included 55 patients who received Levothyroxine suppressive therapy for longer than 6 months with documentation of thyroid stimulating hormone (TSH) suppression level. The control group included 43 patients who were followed up without any treatment. We measured TSH, free T4, and thyroid nodule volume by ultrasound every 6 months. Results In 13 patients (23.6%) of the case group, nodule volume decreased more than 50% after the Levothyroxine suppressive therapy. In 10 (23.2%) of the control group, nodule volume decreased more than 50 % after the follow-up of 6 months. There was no significant difference between the two groups. The change of nodule volume was not related to the TSH suppression level, the number of nodule or the type of nodule. Conclusion We concluded that Levothyroxine suppressive therapy was not effective in volume reduction of benign thyroid nodules.
참고문헌 (19)
- Rojeski MT, "Nodular thyroid disease. Evaluation and management", N Engl J Med, 313(7), pp.428~436 (1985)
- Mazzaferri EL, "Management of a solitary thyroid nodule", N Engl J Med, 328(8), pp.553~559 (1993)
- Hegedüs L, "Clinical practice. The thyroid nodule", N Engl J Med, 351(17), pp.1764~1771 (2004)
- Gharib H, "Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study", N Engl J Med, 317(2), pp.70~75 (1987)
- Horlocker TT, "Prevalnce of incidental nodular thyroid disease detected by high-resolution parathyroid ultrasonography, In Frontiers in thyroidology", pp.1309~1312 (1985), Plenum Medical
- Kim WB, "Prevalence of thyroid cancer in patients with cold thyroid nodules in relation to sex, age, and multinodularity", J Korean Soc Endocrinol, 13(3), pp.366~372 (1998)
- Hooft L, "Practice, efficacy, and costs of thyroid nodule evaluation: a retrospective study in a Dutch university hospital", Thyroid, 14(4), pp.287~293 (2004)
- 윤현대, "갑상선 결절의 감별 진단에 있어서 고해상도 초음파의 유용성", 대한내분비학회지, 20(3), pp.242~251 (2005), 대한내분비학회
- "The thyroid nodule", Ann Intern Med, 96(2), pp.221~232 (1982)
- Ashcraft MW, "Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and find needle aspiration", Head neck Surg, 3(4), pp.297~322 (1981)
- Kim HK, "Percutaneous ethanol injection in benign thyroid nodules", J Korean Soc Endocrinol, 13(3), pp.373~383 (1998)
- Kim YS, "Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience", Thyroid, 16(4), pp.361~367 (2006)
- Westermark K, "Location of epidermal growth factor receptors on porcine thyroid follicle cells and receptor regulation by thyrotropin", Endocrinology, 118(3), pp.1040~1046 (1986)
- Cho YD, "Therapeutic effect of thyroid hormone suppressive therapy for benign thyroid nodule", J Korean Soc Endocrinol, 6(2), pp.141~149 (1991)
- La Rosa GL, "Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid", Ann Intern Med, 122(1), pp.1~8 (1995)
- Papini E, "Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules", J Clin Endocrinol Metab, 83(3), pp.780~783 (1998)
- Larijani B, "Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial", Endocr Pract, 5(5), pp.251~256 (1999)
- Cooper DS, "Clinical review 66: Thyroxine suppression therapy for benign nodular disease", J Clin Endocrinol Metab, 80(2), pp.331~334 (1995)
- Koc M, "Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial", Clin Endocrinol(Oxf), 57(5), pp.621~628 (2002)